Varicella zoster virus infection occurs at a relatively young age in the Netherlands

Vaccine

Volumn 31, Issue 44, 2013, Pages 5127-5133

  Van Lier, Alies ^a   Smits, Gaby ^a   Mollema, Liesbeth ^a   Waaijenborg, Sandra ^a,b   Berbers, Guy ^a   Van Der Klis, Fiona ^a   Boot, Hein ^a   Wallinga, Jacco ^a,b   De Melker, Hester ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Chickenpox; Epidemiology; Serosurveillance; Vaccination; Varicella zoster virus

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); ETHNICITY; FEMALE; HERPES ZOSTER; HUMAN; IMMUNOASSAY; INFANT; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROPREVALENCE; URBANIZATION; VACCINATION; VARICELLA ZOSTER VIRUS;

CHICKENPOX; EPIDEMIOLOGY; SEROSURVEILLANCE; VACCINATION; VARICELLA ZOSTER VIRUS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODIES, VIRAL; CHICKENPOX; CHILD; CHILD DAY CARE CENTERS; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EMIGRANTS AND IMMIGRANTS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; MIDDLE AGED; NETHERLANDS; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; YOUNG ADULT;

EID: 84885427059     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.08.029     Document Type: Article

References (34)

1. Bonanni P., Breuer J., Gershon A., Gershon M., Hryniewicz W., Papaevangelou V., et al. Varicella vaccination in Europe - taking the practical approach. BMC Med. 2009, 7:26.
2. Venice. Report on first survey of immunisation programs in Europe. Rome: Venice; 2007. Available from: []. http://venice.cineca.org/Report_II_WP3.pdf.
3. European Centre for Disease Prevention and Control Vaccination schedules 2013, Available from: http://ecdc.europa.eu/en/activities/surveillance/euvac/schedules/Pages/schedules.aspx. [Retrieved 23.01.13].
4. de Melker H., Berbers G., Hahne S., Rumke H., van den Hof S., de Wit A., et al. The epidemiology of varicella and herpes zoster in the Netherlands: implications for varicella zoster virus vaccination. Vaccine 2006, 24(18):3946-3952.
5. van Lier A., Van Der Maas N.A., Rodenburg G.D., Sanders E.A., de Melker H.E. Hospitalization due to varicella in the Netherlands. BMC Infect Dis 2011, 11:85.
6. Nardone A., de Ory F., Carton M., Cohen D., van Damme P., Davidkin I., et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 2007, 25(45):7866-7872.
7. Van Der Klis F.R.M., Mollema L., Berbers G.A.M., de Melker H.E., Coutinho R.A. Second national serum bank for population-based seroprevalence studies in the Netherlands. Neth J Med 2009, 67(7):301-308.
8. de Melker H.E., Conyn-van Spaendonck M.A. Immunosurveillance and the evaluation of national immunization programmes: a population-based approach. Epidemiol Infect 1998, 121(3):637-643.
9. de Melker H.E., Nagelkerde N.J., Conyn-van Spaendonck M.A. Non-participation in a population-based seroprevalence study of vaccine-preventable diseases. Epidemiol Infect 2000, 124(2):255-262.
10. Smits G.P., van Gageldonk P.G., Schouls L.M., Van Der Klis F.R., Berbers G.A. Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus. Clin Vaccine Immunol 2012, 19(3):396-400.
11. Bickel P.J., Doksum K.A. Mathematical statistics. Basic ideas and selected topics 2001, Prentice-Hall, London.
12. van Baal M., Botterweck A. Hoe gaat het met de kinderen? [How is it with the children] 2003, Webmagazine Statistics Netherlands (Monday 14 July 2003), Dutch.
13. Arvin A.M., Gershon A.A. Varicella-zoster virus: virology and clinical management 2000, Cambridge University Press, Cambridge.
14. Formal child care by duration and age group: children cared for as a percentage of all children in the same age group (less than 3 years). Eurostat 2010, Available from: http://epp.eurostat.ec.europa.eu/tgm/table.do?tab=table&plugin=1&language=en&pcode=tps00185.
15. Mossong J., Hens N., Jit M., Beutels P., Auranen K., Mikolajczyk R., et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008, 5(3):e74.
16. 2. Eurostat 2010, Available from: http://epp.eurostat.ec.europa.eu/tgm/table.do?tab=table&plugin=1&language=en&pcode=tps00003.
17. Population by sex, age, degree of urbanisation of residence and labour status (1000) Eurostat 2010, Available from: http://appsso.eurostat.ec.europa.eu/nui/show.do?dataset=lfsa_pgauws&lang=en.
18. van Rijckevorsel G.G., Bovee L.P., Damen M., Sonder G.J., Schim Van Der Loeff M.F., van den Hoek A. Increased seroprevalence of IgG-class antibodies against cytomegalovirus, parvovirus B19, and varicella-zoster virus in women working in child day care. BMC Public Health 2012, 12:475.
19. van Rijckevorsel G.G., Damen M., Sonder G.J., Schim Van Der Loeff M.F., van den Hoek A. Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population. BMC Infect Dis 2012, 12(1):140.
20. Cohen D.I., Davidovici B.B., Smetana Z., Balicer R.D., Klement E., Mendelson E., et al. Seroepidemiology of varicella zoster in Israel prior to large-scale use of varicella vaccines. Infection 2006, 34(4):208-213.
21. Heininger U., Braun-Fahrlander C., Desgrandchamps D., Glaus J., Grize L., Wutzler P., et al. Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity. Pediatr Infect Dis J 2001, 20(8):775-778.
22. Donker G.A. Continuous morbidity registration sentinel stations the Netherlands 2010 2011, Nivel, Utrecht.
23. Stirbu-Wagner I., Visscher S., Davids R., Gravestein J.V., Ursum J., Van Althuis T., et al. National information network primary care (LINH): facts and figures on primary care in the Netherlands 2011, Nivel/IQ, Utrecht/Nijmegen.
24. Weinberg A., Levin M.J. T cell-mediated immunity. Curr Top Microbiol Immunol 2010, 342:341-357.
25. Harpaz R., Ortega-Sanchez I.R., Seward J.F. Prevention of herpes zoster: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2008, 57(RR-5):1-30.
26. Webster A., Grint P., Brenner M.K., Prentice H.G., Griffiths P.D. Titration of IgG antibodies against varicella zoster virus before bone marrow transplantation is not predictive of future zoster. J Med Virol 1989, 27(2):117-119.
27. Wutzler P., Farber I., Wagenpfeil S., Bisanz H., Tischer A. Seroprevalence of varicella-zoster virus in the German population. Vaccine 2001, 20(1/2):121-124.
28. Tang H., Moriishi E., Okamoto S., Okuno Y., Iso H., Asada H., et al. A community-based survey of varicella-zoster virus-specific immune responses in the elderly. J Clin Virol 2012, 55(1):46-50.
29. Engler R.J.M., Klote M.M. Sex differences in immune responses to vaccines. The Jordan report: accelerated development of vaccines 2012 (NIH Publication No 11-7778) 2012, 19-25. US Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, http://www.niaid.nih.gov/topics/vaccines/Documents/JordanReport2012.pdf.
30. Klein N.P., Holmes T.H., Sharp M.A., Heineman T.C., Schleiss M.R., Bernstein D.I., et al. Variability and gender differences in memory T cell immunity to varicella-zoster virus in healthy adults. Vaccine 2006, 24(33/34):5913-5918.
31. Opstelten W., Van Essen G.A., Schellevis F., Verheij T.J., Moons K.G. Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann Epidemiol 2006, 16(9):692-695.
32. Hope-Simpson R.E. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965, 58:9-20.
33. Plotkin S.A., Orenstein W.A. Offit PA. Vaccines 2008, Elsevier, Philadelphia.
34. Boot H.J., de Melker H.E., Stolk E.A., de Wit G.A., Kimman T.G. Assessing the introduction of universal varicella vaccination in the Netherlands. Vaccine 2006, 24(37-39):6288-6299.